B. Lammek

522 total citations
43 papers, 441 citations indexed

About

B. Lammek is a scholar working on Molecular Biology, Social Psychology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, B. Lammek has authored 43 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 27 papers in Social Psychology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in B. Lammek's work include Neuroendocrine regulation and behavior (27 papers), Chemical Synthesis and Analysis (15 papers) and Neonatal Respiratory Health Research (8 papers). B. Lammek is often cited by papers focused on Neuroendocrine regulation and behavior (27 papers), Chemical Synthesis and Analysis (15 papers) and Neonatal Respiratory Health Research (8 papers). B. Lammek collaborates with scholars based in Poland, United States and Czechia. B. Lammek's co-authors include Piotr Rekowski, Haralambos Gavras, M. Manning, P.K.T. Pang, W. H. Sawyer, Maryann McEnroe, G. Kupryszewski, Yixin Wang, Robert C. Hider and G. Kupryszewski and has published in prestigious journals such as Science, FEBS Letters and Hypertension.

In The Last Decade

B. Lammek

42 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Lammek Poland 12 257 187 89 80 72 43 441
Susan Wong Canada 11 352 1.4× 123 0.7× 39 0.4× 28 0.3× 9 0.1× 15 724
Zachary I. Hodes United States 11 208 0.8× 22 0.1× 81 0.9× 32 0.4× 42 0.6× 21 434
Christiane Mendre France 15 627 2.4× 144 0.8× 340 3.8× 84 1.1× 4 0.1× 39 843
Rebecca C. Allsopp United Kingdom 17 340 1.3× 29 0.2× 40 0.4× 50 0.6× 10 0.1× 24 672
Hasane Ratni Switzerland 12 445 1.7× 46 0.2× 55 0.6× 12 0.1× 278 3.9× 21 606
W. M. Potts United States 12 486 1.9× 22 0.1× 232 2.6× 41 0.5× 15 0.2× 21 769
Joel R. Walker United States 16 518 2.0× 25 0.1× 120 1.3× 18 0.2× 13 0.2× 28 709
Dominique Bonne France 9 251 1.0× 83 0.4× 42 0.5× 28 0.3× 3 0.0× 10 468
Bengt Sandberg Sweden 13 722 2.8× 48 0.3× 622 7.0× 19 0.2× 30 0.4× 38 1.0k
J. D. Gardner United States 21 635 2.5× 41 0.2× 792 8.9× 36 0.5× 19 0.3× 39 1.1k

Countries citing papers authored by B. Lammek

Since Specialization
Citations

This map shows the geographic impact of B. Lammek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Lammek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Lammek more than expected).

Fields of papers citing papers by B. Lammek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Lammek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Lammek. The network helps show where B. Lammek may publish in the future.

Co-authorship network of co-authors of B. Lammek

This figure shows the co-authorship network connecting the top 25 collaborators of B. Lammek. A scholar is included among the top collaborators of B. Lammek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Lammek. B. Lammek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kowalczyk, Wioleta, et al.. (2005). Analogues of arginine vasopressin and its agonist and antagonist modified in the N‐terminal part of the molecule with l‐β‐homophenylalanine. Journal of Peptide Research. 65(4). 465–471. 2 indexed citations
2.
Prahl, Adam, et al.. (2004). Potent bradykinin antagonists containing N‐benzylglycine or N‐benzyl‐l‐alanine in position 8. Journal of Peptide Research. 63(1). 29–35. 4 indexed citations
3.
Kowalczyk, Wioleta, Adam Prahl, B. Hartrodt, et al.. (2004). Analogues of arginine vasopressin modified in the N‐terminal part of the molecule with enantiomers of N‐methylphenylalanine. Journal of Peptide Research. 63(5). 420–425. 5 indexed citations
4.
Kowalczyk, Wioleta, et al.. (2004). Cis/trans conformational equilibrium across the N‐methylphenylalanine2‐ N‐methylphenylalanine3 peptide bond of arginine vasopressin analogs. Journal of Peptide Research. 63(4). 333–346. 12 indexed citations
5.
Prahl, Adam, et al.. (2003). New Bradykinin Analogues Modified in Position 6 and 7 with Naphthylalanine. Polish Journal of Chemistry. 77(7). 881–887. 4 indexed citations
6.
Prahl, Adam, et al.. (2002). New bradykinin Analogues Substituted in Positions 6 and 7 with Enantiomers of N-Methylphenylalanine. Polish Journal of Chemistry. 76(5). 713–719. 1 indexed citations
7.
Jastrzębska, Beata, et al.. (2002). Analogues of arginine vasopressin (AVP) modified in the N-terminal part of the molecule with N-benzylglycine. Polish Journal of Chemistry. 76(6). 823–830. 2 indexed citations
8.
Ślusarz, Rafał, Rajmund Kaźmierkiewicz, & B. Lammek. (2000). Theoretical conformational analysis of six arginine vasopressin analogs with the l‐naphthylalanine in position 3. Journal of Peptide Research. 56(6). 352–359. 3 indexed citations
9.
Kaźmierkiewicz, Rajmund, Cezary Czaplewski, B. Lammek, & Jerzy Ciarkowski. (1999). Essential dynamics/factor analysis for the interpretation of molecular dynamics trajectories. Journal of Computer-Aided Molecular Design. 13(1). 21–33. 10 indexed citations
10.
Lammek, B., et al.. (1999). Analogs of arginine vasopressin modified in position 3 with (R)‐α‐ hydroxymethylphenylalanine. Journal of Peptide Research. 53(5). 554–559. 8 indexed citations
11.
Prahl, Adam, et al.. (1997). Antagonists of bradykinin modified with conformationally restricted dipeptide fragment. Polish Journal of Chemistry. 71(7). 929–935. 12 indexed citations
12.
Lammek, B., Piotr Rekowski, Henryk I. Trzeciak, et al.. (1997). Influence of L‐naphthylalanine in position 3 of AVP and its analogues on their pharmacological properties. Journal of Peptide Research. 49(3). 261–268. 23 indexed citations
13.
Lammek, B.. (1994). DESIGN AND SYNTHESIS OF B2-ANTAGONISTS OF BRADYKININ. Polish Journal of Chemistry. 68(5). 913–920. 12 indexed citations
14.
Sawyer, W. H., et al.. (1991). Cyclic and linear vasopressin V1 and V1/V2 antagonists containing arginine in the 4-position. Cellular and Molecular Life Sciences. 47(1). 83–86. 1 indexed citations
15.
Lammek, B., Yixin Wang, & Haralambos Gavras. (1990). A new highly potent antagonist of bradykinin. Peptides. 11(5). 1041–1043. 33 indexed citations
16.
Kaliszan, Roman, et al.. (1988). Constrictory activity of three new arginine-vasopressin (AVP) analogues (ALA-AVP, SER-ALA-AVP, THR-SER-ALA-AVP) towards isolated rat tail artery as related to AVP alone. Pharmacological Research Communications. 20(5). 377–381. 2 indexed citations
17.
Hider, Robert C., G. Kupryszewski, Piotr Rekowski, & B. Lammek. (1988). Origin of the positive 225–230 nm circular dichroism band in proteins. Biophysical Chemistry. 31(1-2). 45–51. 43 indexed citations
18.
Elands, Jack, Claude Barberis, Serge Jard, et al.. (1988). 125I‐d(CH2)5[Tyr(Me)2,Tyr(NH2)9]AVP: Iodination and binding characteristics of a vasopressin receptor ligand. FEBS Letters. 229(2). 251–255. 19 indexed citations
19.
Lammek, B., Piotr Rekowski, G. Kupryszewski, Per Melin, & Ulf Ragnarsson. (1988). Synthesis of arginine-vasopressins, modified in positions 1 and 2, as antagonists of the vasopressor response to the parent hormone. Journal of Medicinal Chemistry. 31(3). 603–606. 34 indexed citations
20.
Lammek, B., Piotr Rekowski, G. Kupryszewski, Per Melin, & Ulf Ragnarsson. (1987). Synthesis of three NH2-terminally extended arginine-vasopressins with prolonged biological activities. Cellular and Molecular Life Sciences. 43(11-12). 1211–1212. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Wong Breakdown of academic impact, for papers by Zachary I. Hodes Breakdown of academic impact, for papers by Christiane Mendre Breakdown of academic impact, for papers by Rebecca C. Allsopp Breakdown of academic impact, for papers by Hasane Ratni Breakdown of academic impact, for papers by W. M. Potts Breakdown of academic impact, for papers by Joel R. Walker Breakdown of academic impact, for papers by Dominique Bonne Breakdown of academic impact, for papers by Bengt Sandberg Breakdown of academic impact, for papers by J. D. Gardner
Rankless by CCL
2026